Mouse model study uncovers promising drug target for AML treatment
Scientists at UT Health San Antonio have identified PSPC1 in…
Scientists at UT Health San Antonio have identified PSPC1 in mouse models as a promising new drug target for acute myeloid leukaemia (AML), a deadly blood cancer with limited treatment options.